Abstract
Cigarette smoking is strongly correlated with many diseases like cancer, cardiovascular disease and macular degeneration. Nicotine, the main active and addictive component of tobacco smoke has recently been shown to enhance angiogenesis in many experimental systems and animal models. The pro-angiogenic activity of nicotine is mediated by nicotinic acetylcholine receptors, particularly the alpha 7 subunit, that are expressed on a variety of non-neuronal cells including those in the vasculature such as endothelial cells and smooth muscle cells. The present review focuses on the role of α7nAChR in mediating the pro-angiogenic effects of nicotine and describes the molecular mechanisms involved in nicotine-induced angiogenesis as well as epithelial to mesenchymal transition. These observations on nicotine function highlight the therapeutic potential of α7nAChR agonists and antagonists for combating angiogenesis related diseases.
Keywords: signaling, arteriogenesis, macular degeneration, cancer, metastasis, smoking, cholinergic system, angiogenesis, neovascularization, EMT
Current Drug Targets
Title:α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Volume: 13 Issue: 5
Author(s): Smitha Pillai and Srikumar Chellappan
Affiliation:
Keywords: signaling, arteriogenesis, macular degeneration, cancer, metastasis, smoking, cholinergic system, angiogenesis, neovascularization, EMT
Abstract: Cigarette smoking is strongly correlated with many diseases like cancer, cardiovascular disease and macular degeneration. Nicotine, the main active and addictive component of tobacco smoke has recently been shown to enhance angiogenesis in many experimental systems and animal models. The pro-angiogenic activity of nicotine is mediated by nicotinic acetylcholine receptors, particularly the alpha 7 subunit, that are expressed on a variety of non-neuronal cells including those in the vasculature such as endothelial cells and smooth muscle cells. The present review focuses on the role of α7nAChR in mediating the pro-angiogenic effects of nicotine and describes the molecular mechanisms involved in nicotine-induced angiogenesis as well as epithelial to mesenchymal transition. These observations on nicotine function highlight the therapeutic potential of α7nAChR agonists and antagonists for combating angiogenesis related diseases.
Export Options
About this article
Cite this article as:
Smitha Pillai and Srikumar Chellappan , α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition , Current Drug Targets 2012; 13 (5) . https://dx.doi.org/10.2174/138945012800398847
DOI https://dx.doi.org/10.2174/138945012800398847 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heart Failure Models: Traditional and Novel Therapy
Current Vascular Pharmacology Myocardial Energetics in Left Ventricular Hypertrophy
Current Cardiology Reviews Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Glucagon Like Peptide-1 and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry Helicobacter Pylori Infection, Immune Response and Vaccination
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial
Current Rheumatology Reviews Thiazide Diuretics: 50 Years and Beyond
Current Hypertension Reviews Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Imaging of Visceral Adipose Tissue: An Emerging Diagnostic Tool and Therapeutic Target
Current Drug Targets - Cardiovascular & Hematological Disorders Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery
Current Pharmaceutical Design Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Retinal Vascular Features for Cardio Vascular Disease Prediction: A Review
Recent Patents on Computer Science A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging
Current Neuropharmacology Recent Development on Anti-Obesity Compounds and their Mechanisms of Action: A Review
Current Medicinal Chemistry